Iratumumab
id:
iratumumab-239-2376255
title:
Iratumumab
text:
Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease. This drug was developed by Medarex, which was later acquired by Bristol-Myers Squibb. The FDA granted orphan drug designation for Hodgkin's lymphoma in 2004. In 2009, development was suspended with no explanation given.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Iratumumab
date created:
date modified:
2023-05-14T00:48:00Z
main entity:
{"identifier":"Q3801853","url":"https://www.wikidata.org/entity/Q3801853"}
image:
fields total:
13
integrity:
14